1-20 of 21586
Sort by
Journal Article
ACCEPTED MANUSCRIPT
Keita Kohno and Makoto Tsuda
International Immunology, dxaf022, https://doi.org/10.1093/intimm/dxaf022
Published: 19 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Erkhembayar Shinebaatar and others
International Immunology, dxaf021, https://doi.org/10.1093/intimm/dxaf021
Published: 14 April 2025
Image
Published: 14 April 2025
Graphical Abstract Graphical abstract
Journal Article
International Immunology, Volume 37, Issue 5, May 2025, Pages 251–252, https://doi.org/10.1093/intimm/dxaf011
Published: 07 April 2025
Image
Published: 29 March 2025
Graphical Abstract Graphical abstract
Image
Published: 29 March 2025
Graphical Abstract Graphical Abstract
Journal Article
ACCEPTED MANUSCRIPT
Yusaku Momoi and others
International Immunology, dxaf020, https://doi.org/10.1093/intimm/dxaf020
Published: 29 March 2025
Journal Article
ACCEPTED MANUSCRIPT
Katsuki Iwahori and others
International Immunology, dxaf019, https://doi.org/10.1093/intimm/dxaf019
Published: 29 March 2025
Journal Article
ACCEPTED MANUSCRIPT
Rie Hasebe and others
International Immunology, dxaf009, https://doi.org/10.1093/intimm/dxaf009
Published: 29 March 2025
Journal Article
ACCEPTED MANUSCRIPT
Takahisa Yoshikawa and Motoko Yanagita
International Immunology, dxaf017, https://doi.org/10.1093/intimm/dxaf017
Published: 24 March 2025
Image
Published: 24 March 2025
Graphical Abstract Graphical abstract
Journal Article
ACCEPTED MANUSCRIPT
Isabelle Jia Hui Foo and others
International Immunology, dxaf018, https://doi.org/10.1093/intimm/dxaf018
Published: 24 March 2025
Image
Published: 24 March 2025
Graphical Abstract Graphical abstract
Journal Article
ACCEPTED MANUSCRIPT
Shusei Fujioka and others
International Immunology, dxaf014, https://doi.org/10.1093/intimm/dxaf014
Published: 21 March 2025
Journal Article
Yu Hidaka and others
International Immunology, dxaf013, https://doi.org/10.1093/intimm/dxaf013
Published: 21 March 2025
Journal Article
Takayoshi Ito and Hisako Kayama
International Immunology, dxaf015, https://doi.org/10.1093/intimm/dxaf015
Published: 21 March 2025
Image
Published: 21 March 2025
Figure 2. Study design. Participants received the first BNT162b2 dose on day 0 and the second on around day 21. The sampling points were set with an allowance: 7–21 days after the first dose (Post 1), 31–39 days after the first dose (Post 2). The actual vaccinated and sampling days are described in the Resul
Image
Published: 21 March 2025
Figure 3. Changes in anti-RBD IgG levels. (A) Anti-RBD IgG levels at each time point (pre-vaccination, following the first dose, and following the second dose). (B) Anti-RBD IgG levels plotted by days since the first and second vaccinations, with day 0 set as the date of each respective dose.
Image
Published: 21 March 2025
Figure 3. Fibrosis is a common complication in UC and CD patients. (A) Activation of TLR–MyD88 signaling by bacterial flagellin facilitates the production of collagen and fibronectin in the myofibroblasts present in the intestinal mucosa of UC and CD patients. (B) Cadherin 11 (CDH11) promotes collagen synthes
Image
Published: 21 March 2025
Graphical Abstract Graphical abstract